Investigation of brain iron levels in Chinese patients with Alzheimer’s disease

Introduction We aimed (i) to explore the diagnostic value of deep gray matter magnetic susceptibility in Alzheimer’s disease (AD) in China and (ii) to analyze its correlation with neuropsychiatric scales. Moreover, we conducted subgroup analysis based on the presence of the APOE-ε4 gene to improve the diagnosis of AD. Methods From the prospective studies of the China Aging and Neurodegenerative Initiative (CANDI), a total of 93 subjects who could undergo complete quantitative magnetic susceptibility imaging and APOE-ε4 gene detection were selected. Differences in quantitative susceptibility mapping (QSM) values between and within groups, including AD patients, individuals with mild cognitive impairment (MCI), and healthy controls (HCs), both APOE-ε4 carriers and non-carriers, were analyzed. Results In primary analysis, the magnetic susceptibility values of the bilateral caudate nucleus and right putamen in the AD group and of the right caudate nucleus in the MCI group were significantly higher than those in the HCs group (P < 0.05). In APOE-ε4 non-carriers, there were significant differences in more regions between the AD, MCI, and HCs groups, such as the left putamen and the right globus pallidus (P < 0.05). In subgroup analysis, the correlation between QSM values in some brain regions and neuropsychiatric scales was even stronger. Discussion Exploration of the correlation between deep gray matter iron levels and AD may provide insight into the pathogenesis of AD and facilitate early diagnosis in elderly Chinese. Further subgroup analysis based on the presence of the APOE-ε4 gene may further improve the diagnostic efficiency and sensitivity.

[1]  2023 Alzheimer's disease facts and figures , 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  Ji-Rong Wen,et al.  Altered brain iron depositions from aging to Parkinson's disease and Alzheimer's disease: A quantitative susceptibility mapping study , 2022, NeuroImage.

[3]  F. Pasquier,et al.  Quantitative susceptibility mapping demonstrates different patterns of iron overload in subtypes of early-onset Alzheimer’s disease , 2022, European Radiology.

[4]  F. Gao,et al.  A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[5]  W. Moon,et al.  Magnetic susceptibility in the deep gray matter may be modulated by apolipoprotein E4 and age with regional predilections: a quantitative susceptibility mapping study , 2022, Neuroradiology.

[6]  Yige Wang,et al.  Associations of cortical iron accumulation with cognition and cerebral atrophy in Alzheimer’s disease , 2022, Quantitative imaging in medicine and surgery.

[7]  P. Paez,et al.  H‐ferritin expression in astrocytes is necessary for proper oligodendrocyte development and myelination , 2021, Glia.

[8]  Benjamin C. Tendler,et al.  Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging , 2021, bioRxiv.

[9]  J. Weuve,et al.  Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020–2060) , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[10]  B. Hyman,et al.  APOE and Alzheimer’s Disease: Advances in Genetics, Pathophysiology, and Therapeutic Approaches. , 2021, The Lancet Neurology.

[11]  Sungshin Kim,et al.  Spatiotemporal dissociation of fMRI activity in the caudate nucleus underlies human de novo motor skill learning , 2020, Proceedings of the National Academy of Sciences.

[12]  Christian Enzinger,et al.  Cross-sectional and Longitudinal Assessment of Brain Iron Level in Alzheimer Disease Using 3-T MRI. , 2020, Radiology.

[13]  R. Egli,et al.  Effects of Alzheimer’s disease and formalin fixation on the different mineralised-iron forms in the human brain , 2020, Scientific Reports.

[14]  O. Hansson,et al.  Relationship between cortical iron and tau aggregation in Alzheimer’s disease , 2020, Brain : a journal of neurology.

[15]  T. Südhof,et al.  Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk , 2019, The Journal of Neuroscience.

[16]  P. Robert,et al.  Alzheimer's disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems , 2019, PloS one.

[17]  Chunlei Liu,et al.  Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI , 2019, NeuroImage.

[18]  J. Schneider,et al.  Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology , 2019, Molecular Psychiatry.

[19]  P. Adlard,et al.  Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration , 2018, Front. Mol. Neurosci..

[20]  Peter C. M. van Zijl,et al.  Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age , 2018, NeuroImage.

[21]  Lei Wang,et al.  Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease. , 2018, ACS chemical neuroscience.

[22]  Qing X. Yang,et al.  Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice. , 2018, Metallomics : integrated biometal science.

[23]  Ronald C. Petersen,et al.  Practice guideline update summary: Mild cognitive impairment , 2018, Neurology.

[24]  Joseph J. Gallagher,et al.  Iron Biochemistry is Correlated with Amyloid Plaque Morphology in an Established Mouse Model of Alzheimer's Disease. , 2017, Cell chemical biology.

[25]  Emily C. Collins,et al.  Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease , 2017, NeuroImage.

[26]  T. Hirai,et al.  Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care , 2017, Journal of magnetic resonance imaging : JMRI.

[27]  A. Bush,et al.  Evidence that iron accelerates Alzheimer’s pathology: a CSF biomarker study , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[28]  Yi Wang,et al.  Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease☆ , 2017, NeuroImage: Clinical.

[29]  Olivier Salvado,et al.  Cerebral quantitative susceptibility mapping predicts amyloid-&bgr;-related cognitive decline , 2017, Brain : a journal of neurology.

[30]  A. F. Gietl,et al.  Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment , 2016, Scientific Reports.

[31]  Josep Samitier,et al.  Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer’s disease , 2015, Scientific Reports.

[32]  Wei Li,et al.  Susceptibility‐weighted imaging and quantitative susceptibility mapping in the brain , 2015, Journal of magnetic resonance imaging : JMRI.

[33]  Wei Cao,et al.  A method for estimating and removing streaking artifacts in quantitative susceptibility mapping , 2015, NeuroImage.

[34]  Yi Wang,et al.  Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker , 2014, Magnetic resonance in medicine.

[35]  Christian Langkammer,et al.  Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan , 2014, Human brain mapping.

[36]  Saifeng Liu,et al.  Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging , 2013, NeuroImage.

[37]  Peng Lei,et al.  A delicate balance: Iron metabolism and diseases of the brain , 2013, Front. Aging Neurosci..

[38]  Ferdinand Schweser,et al.  Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study , 2012, NeuroImage.

[39]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[40]  Bing Wu,et al.  Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.

[41]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[42]  Kyle L. Morris,et al.  Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation* , 2010, The Journal of Biological Chemistry.

[43]  Wei Wang,et al.  Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease. , 2009, Radiology.

[44]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Connor,et al.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.

[46]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[47]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[48]  Won-Jin Moon,et al.  Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging. , 2016, Journal of Alzheimer's disease : JAD.

[49]  M. Ganguli,et al.  Practice guideline update summary: Mild cognitive impairment Report of theGuidelineDevelopment, Dissemination, and Implementation Subcommittee of the American Academy ofNeurology , 2022 .